Patents by Inventor Ronald E. Strohbehn

Ronald E. Strohbehn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100029564
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Application
    Filed: July 24, 2009
    Publication date: February 4, 2010
    Applicant: BIOVA, L.L.C.
    Inventors: RONALD E. STROHBEHN, LISA R. ETZEL, JESSE FIGGINS
  • Publication number: 20090104173
    Abstract: The process for solubilizing proteinaceous material of the present invention includes subjecting the proteinaceous material to a sufficient amount of a basic solution to obtain a supernatant that has a basic pH and exposing the supernatant to the basic solution for a sufficient length of time and temperature for hydrolysis to occur. The process also includes cooling the mixture of the supernatant and proteinaceous material and optionally acidifying the mixture. This process may also include recovering the solubilized protein from the supernatant for use in various applications. Also provided herein is a composition of solubilized proteins from eggshell membrane obtained using processes of the present invention.
    Type: Application
    Filed: October 17, 2008
    Publication date: April 23, 2009
    Applicant: BIOVA, L.L.C.
    Inventors: RONALD E. STROHBEHN, LISA R. ETZEL, JESSE FIGGINS
  • Publication number: 20080213263
    Abstract: Methods and compositions are disclosed for modulating the immune system of animals. Applicants have identified that oral administration of immunoglobulin or plasma fractions purified from animal serum can modulate serum IgG and/or TNF-? levels for treatment of autoimmune disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
    Type: Application
    Filed: October 29, 2007
    Publication date: September 4, 2008
    Inventors: Joy Campbell, Ronald E. Strohbehn, Eric M. Weaver, Barton S. Borg, Louis E. Russell, Francisco Javier Polo Pozo, John D. Arthington, James D. Quigley
  • Publication number: 20080206436
    Abstract: The present invention relates to methods for the separation of various components from eggs. More particularly, the present invention relates to methods for the separation of proteins and lipids from eggs, including technical eggs (inedible) or edible eggs, yolks or whites, which comprises cross-linking the lipids of eggs with a cross-linking reagent. In an embodiment, the method includes separating the proteins from the cross-linked lipids. In an embodiment, the method includes the separation of various components associated with the cross-linked lipids. The methods disclosed herein allow for the isolation of multiple different components from the egg in an efficient, cost-effective manner without compromising the recovery process of the components or their subsequent utility in various applications or compositions. The compositions and isolated components obtained by the methods of the invention can be used in pharmaceutical, medical, nutritional, cosmetic or health applications.
    Type: Application
    Filed: January 9, 2008
    Publication date: August 28, 2008
    Applicant: BIOVA, L.L.C.
    Inventors: RONALD E. STROHBEHN, JESSE I. FIGGINS
  • Publication number: 20080166447
    Abstract: The present invention relates to methods for the separation of various components from eggs. More particularly, the present invention relates to methods for the separation of proteins and lipids from eggs, including technical eggs (inedible) or edible eggs, yolks or whites, which comprises cross-linking the lipids of eggs with a cross-linking reagent. In an embodiment, the method includes separating the proteins from the cross-linked lipids. In an embodiment, the method includes the separation of various components associated with the cross-linked lipids. The methods disclosed herein allow for the isolation of multiple different components from the egg in an efficient, cost-effective manner without compromising the recovery process of the components or their subsequent utility in various applications or compositions. The compositions and isolated components obtained by the methods of the invention can be used in pharmaceutical, medical, nutritional, cosmetic or health applications.
    Type: Application
    Filed: January 9, 2008
    Publication date: July 10, 2008
    Applicant: BIOVA, L.L.C.
    Inventors: RONALD E. STROHBEHN, JESSE I. FIGGINS
  • Publication number: 20080138340
    Abstract: Methods and compositions are disclosed for modulating the immune system of animals. Applicant has identified that oral administration of immunoglobulins purified from animal blood can modulate serum IgG levels for treatment of immune dysfunction disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 12, 2008
    Inventors: Joy M. Campbell, Ronald E. Strohbehn, Eric M. Weaver, Barton S. Borg, Louis E. Russell, Francisco Javier Polo Pozo, John D. Arthington, James D. Quigley
  • Publication number: 20080124321
    Abstract: A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 29, 2008
    Inventors: Ralph D. Yoder, Ronald E. Strohbehn
  • Patent number: 7244427
    Abstract: A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: July 17, 2007
    Assignee: The Lauridsen Group Incorporated
    Inventors: Ralph D. Yoder, Ronald E. Strohbehn
  • Patent number: 6939954
    Abstract: A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: September 6, 2005
    Assignee: The Lauridsen Group Incorporated
    Inventors: Ralph D. Yoder, Ronald E. Strohbehn
  • Publication number: 20040202660
    Abstract: Methods and compositions are disclosed for modulating the immune system of animals. Applicant has identified that oral administration of immunoglobulin or plasma fractions purified from animal serum can modulate serum IgG and/or TNF-&Dgr; levels for treatment of autoimmune disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
    Type: Application
    Filed: May 20, 2004
    Publication date: October 14, 2004
    Inventors: Joy Campbell, Ronald E. Strohbehn, Eric M. Weaver, Barton S. Borg, Louis E. Russell, Francisco Javier Polo Pozo, John D. Arthington, James D. Quiglev
  • Publication number: 20040146565
    Abstract: A pharmaceutical composition used as an anti-inflammatory is prepared. The composition comprises a plasma fraction separated from blood plasma and/or in combination with a pharmaceutical carrier. In a preferred method, the plasma fraction is separated from the blood plasma by mixing with from 3% to 10% by weight of the plasma fraction of silica and thereafter centrifuging to allow the plasma fraction to be precipitated out in conjunction with the silica. They are thereafter separated.
    Type: Application
    Filed: January 28, 2003
    Publication date: July 29, 2004
    Applicant: Lauridsen Group Incorporated
    Inventors: Ronald E. Strohbehn, Joy M. Campbell, Eric M. Weaver, Jesse Irving Figgins
  • Publication number: 20030190314
    Abstract: Methods and compositions are disclosed for the dietary modulation of the immune system and gut microbial response in animals. Applicant has identified that oral administration of a supplemental spray dried plasma purified from animal serum can modulate serum IgG levels for treatment in such things as diminished immune capacity, intestinal microbial balance, autoimmune disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
    Type: Application
    Filed: February 25, 2003
    Publication date: October 9, 2003
    Applicant: The Lauridsen Group
    Inventors: Joy M. Campbell, Ronald E. Strohbehn, Eric M. Weaver, Barton S. Borg, Louis E. Russell, Francisco Javier Polo Pozo, John D. Arthington, James D. Quigley
  • Publication number: 20030103962
    Abstract: Methods and compositions are disclosed for modulating the immune system of animals. Applicant has identified that oral administration of immunoglobulins purified from animal blood can modulate serum IgG levels for treatment of immune dysfunction disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
    Type: Application
    Filed: October 9, 2001
    Publication date: June 5, 2003
    Inventors: Joy M. Campbell, Ronald E. Strohbehn, Eric M. Weaver, Barton S. Borg, Louis E. Russell, Francisco Javier Polo Pozo, John D. Arthington, James D. Quigley
  • Publication number: 20030099633
    Abstract: Methods and compositions are disclosed for modulating the immune system of animals. Applicant has identified that oral administration of immunoglobulins purified from animal serum can modulate serum IgG levels for treatment of autoimmune disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans.
    Type: Application
    Filed: October 9, 2001
    Publication date: May 29, 2003
    Inventors: Joy M. Campbell, Ronald E. Strohbehn, Eric M. Weaver, Barton S. Borg, Louis E. Russell, Francisco Javier Polo Pozo, John D. Arthington, James D. Quigley
  • Publication number: 20030026845
    Abstract: According to the invention, Applicants have identified a clarification process which is simple and quick and provides a protein isolate of greater than 90% whey protein which may then optionally be further purified to select out individual proteins. The process involves a number of steps, the order of which is critical, and novel lipid removal techniques to achieving the highly pure and clarified protein isolate of the invention.
    Type: Application
    Filed: June 18, 2001
    Publication date: February 6, 2003
    Inventors: Lisa R. Etzel, Ronald E. Strohbehn
  • Publication number: 20020147313
    Abstract: A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.
    Type: Application
    Filed: August 27, 2001
    Publication date: October 10, 2002
    Inventors: Ralph D. Yoder, Ronald E. Strohbehn
  • Publication number: 20020143157
    Abstract: A new protein derived from acid hydrolyzed IgG concentrate which has a molecular weight of about 55,000, and is activated by heat within the defined narrow temperature range provides resulting product that has a protective mechanism for bacterial and viral invasion of living cells.
    Type: Application
    Filed: January 30, 2001
    Publication date: October 3, 2002
    Inventors: Ralph D. Yoder, Ronald E. Strohbehn